| Citation: |
DAI Chen, HUANG Tianfeng, LU Dahao. Role and mechanism of P2Y12 receptor in microglia in central post-stroke pain in mice[J]. Journal of Clinical Medicine in Practice, 2024, 28(13): 24-29. DOI: 10.7619/jcmp.20240524
|
To evaluate the role of P2Y12 receptor in microglia in central post-stroke pain (CPSP) in mice and its mechanism.
Thirty-two specific pathogen-free(SPF)-grade male C57BL/6J mice were selected, aged 7 to 8 weeks, weighing 25 to 30 g, were divided into four groups using a random number table method: C group (sham operation group, n=8), CPSP group (n=8), CPSP-M group (CPSP plus P2Y12 receptor inhibitor MRS2395, n=8) and C-M group (sham operation plus P2Y12 receptor inhibitor MRS2395, n=8). CPSP model was induced by injecting 10 nL type Ⅳ collagenase(0.001 U/nL) into the right ventral posterior medial nucleus andventral posterior lateral nucleus. MRS2395(1.5 mg/kg) was injected intraperitoneally at 30 min before model preparation in CPSP-M group and C-M group and then injected once a day for 5 consecutive days, mice in C group and CPSP group were given saline at the same volume. Before the modeling (T0) and 3, 7 and 14 days (T1, T2, T3) after the establishment of the model, the thermal withdrawal latency (TWL), cold withdrawal latency (CWL) and paw withdrawal frequency (PWF) were measured. The mice were then sacrificed and the brain tissues were obtained for observing the location of P2Y12receptor by double immunofluorescence staining and the pathological changes by HE staining, and for determination of the expression levels of P2Y12 receptor, toll-like receptor 4 (TLR4), phospho-nuclear factor-κB p65 (p-NF-κB p65) and NF-κB p65 by western blot.
P2Y12 receptor was co-localized only with microglia, but not with neurons or astrocytes in brain tissue of CPSP group. Compared with C group, the TWL and CWL were significantly reduced and the PWF was significantly increased at T1 to T3, cerebral injury was aggravated significantly and the expressions of P2Y12 receptor, TLR4 and p-NF-κB p65 in brain tissue were up-regulated in CPSP group and CPSP-M group (P < 0.05). There was no statistically significant difference between C group and C-M group in the above indicators (P>0.05). Compared with CPSP group, the TWL and CWL were significantly prolonged and the PWF was significantly reduced at T1 to T3, cerebral injury was relieved significantly and the expressions of P2Y12 receptor, TLR4 and p-NF-κB p65 in brain tissue were down-regulated in CPSP group and CPSP-M group (P < 0.05).
P2Y12 receptors in microglia may be involved in the development of CPSP by activating TLR4/NF-κB signaling pathway in mice.
| [1] |
ZHENG B, YANG J, LI Y, et al. Pharmacotherapies for central post-stroke pain: a systematic review and network meta-analysis[J]. Oxid Med Cell Longev, 2022, 2022: 3511385.
|
| [2] |
INFANTINO R, SCHIANO C, LUONGO L, et al. MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia[J]. Neurobiol Dis, 2022, 164: 105611.
|
| [3] |
贾可欣, 仲格嘉, 朱春燕, 等. 如意珍宝丸对小鼠丘脑出血后中枢痛的干预作用[J]. 中国实验方剂学杂志, 2022, 28(16): 82-89.
|
| [4] |
HUANG T F, FU G L, GAO J, et al. Fgr contributes to hemorrhage-induced thalamic pain by activating NF-κB/ERK1/2 pathways[J]. JCI Insight, 2020, 5(20): e139987.
|
| [5] |
HUANG T F, LI Y, HU W Q, et al. Dexmedetomidine attenuates haemorrhage-induced thalamic pain by inhibiting the TLR4/NF-κB/ERK1/2 pathway in mice[J]. Inflammopharmacology, 2021, 29(6): 1751-1760.
|
| [6] |
ZHANG X G, LI G L. P2Y receptors in neuropathic pain[J]. Pharmacol Biochem Behav, 2019, 186: 172788.
|
| [7] |
MA B B, MONTGOMERY A P, CHEN B L, et al. Strategies for targeting the P2Y12 receptor in the central nervous system[J]. Bioorg Med Chem Lett, 2022, 71: 128837.
|
| [8] |
SHI Y, WEN H Z, CUI J, et al. Ulinastatin inhibits microglia activation in spinal cord via P2Y12 receptor in a rat neuropathic pain model[J]. J Histotechnol, 2023, 46(1): 39-53.
|
| [9] |
KUAN Y H, SHIH H C, TANG S C, et al. Targeting P(2)X(7) receptor for the treatment of central post-stroke pain in a rodent model[J]. Neurobiol Dis, 2015, 78: 134-145.
|
| [10] |
李航, 王泽颖, 王玉勇. 卒中后中枢性疼痛的中西医研究进展[J]. 湖南中医杂志, 2022, 38(10): 195-199.
|
| [11] |
陶毅航. 星状/颈上神经节阻滞对大鼠出血性脑卒中后中枢痛的治疗作用及机制研究[D]. 延安: 延安大学, 2023.
|
| [12] |
WAN L, LI Z F, LIU T T, et al. Epoxyeicosatrienoic acids: emerging therapeutic agents for central post-stroke pain[J]. Pharmacol Res, 2020, 159: 104923.
|
| [13] |
SAXENA S, KRUYS V, VAMECQ J, et al. The role of microglia in perioperative neuroinflammation and neurocognitive disorders[J]. Front Aging Neurosci, 2021, 13: 671499.
|
| [14] |
LU H F, XU C Y, ZHANG L, et al. A new central post-stroke pain rat model: autologous blood injected thalamic hemorrhage involved increased expression of P2X4 receptor[J]. Neurosci Lett, 2018, 687: 124-130.
|
| [15] |
牛翻燕, 项文平, 薛慧, 等. 小胶质细胞和星形胶质细胞中的P2Y受体在中枢神经系统病变中的作用机制研究进展[J]. 中国实用神经疾病杂志, 2022, 25(3): 386-391.
|
| [16] |
曾俊伟, 刘晓红, 蒋慧, 等. 脊髓背角P2Y12受体/P38MAPK参与MRS2395对CCI大鼠的镇痛作用[J]. 中国疼痛医学杂志, 2015, 21(1): 15-20, 27.
|
| [17] |
CHEN X T, CHEN L P, FAN L J, et al. Microglial P2Y12 signaling contributes to cisplatin-induced pain hypersensitivity via IL-18-mediated central sensitization in the spinal cord[J]. J Pain, 2023, 24(5): 901-917.
|
| [18] |
ISLAM R, VRIONIS F, HANAFY K A. Microglial TLR4 is critical for neuronal injury and cognitive dysfunction in subarachnoid hemorrhage[J]. Neurocrit Care, 2022, 37(3): 761-769.
|
| [19] |
CHANG S Q, LI X, ZHENG Y C, et al. Kaempferol exerts a neuroprotective effect to reduce neuropathic pain through TLR4/NF-κB signaling pathway[J]. Phytother Res, 2022, 36(4): 1678-1691.
|
| [20] |
ZHAO Y X, YAO M J, LIU Q, et al. Electroacupuncture treatment attenuates paclitaxel-induced neuropathic pain in rats via inhibiting spinal Glia and the TLR4/NF-κB pathway[J]. J Pain Res, 2020, 13: 239-250.
|
| [21] |
SUN N H, CHU L C, YUAN L, et al. Inactivation of P2YR12 contributes to isoflurane-induced neuronal injury by altering TLR-4/BDNF/TNF-Α[J]. Folia Neuropathol, 2019, 57(2): 161-169.
|
| [1] | CAO Lan, TAO Yujian, ZHAO Yuanlu, ZHANG Pan. Analysis in risk factors of solitary pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 38-40, 44. DOI: 10.7619/jcmp.20200457 |
| [2] | GUO Zhongqing, AN Xing, YANG Chao. Analysis on risk factors of noscomial infectionfollowing radiotherapy in tumor patients[J]. Journal of Clinical Medicine in Practice, 2019, 23(8): 81-84. DOI: 10.7619/jcmp.201908023 |
| [3] | CHENG Liqun. Correlation between leukoaraiosis and cerebral infarction and risk factors[J]. Journal of Clinical Medicine in Practice, 2018, (7): 42-44. DOI: 10.7619/jcmp.201807011 |
| [4] | LIAO Zhongmei, TANG Zhihong. Risk factors and nursing intervention measures of stress hyperglycemia in ICU patients[J]. Journal of Clinical Medicine in Practice, 2017, (20): 35-37,43. DOI: 10.7619/jcmp.201720011 |
| [5] | TAN Zhihui, TANG Qiqun, CHENG Jie. The status and influencing factors of work values of ICU nurses[J]. Journal of Clinical Medicine in Practice, 2017, (10): 130-133. DOI: 10.7619/jcmp.201710039 |
| [6] | SONG Lihua, FU Cuiyan, LIU Yashuang, YANG Lina. Risk factors and preventive nursing measures of ventilator-associated pneumonia in ICU[J]. Journal of Clinical Medicine in Practice, 2016, (9): 50-53. DOI: 10.7619/jcmp.201609014 |
| [7] | ZHANG Bing. Risk factors and countermeasures of ICU nurses with occupational burnout[J]. Journal of Clinical Medicine in Practice, 2016, (2): 89-92. DOI: 10.7619/jcmp.201602028 |
| [8] | XIE Jinlan, QIN Ying, SHI Chunjuan, ZENG Tao, YAO Hui, DOU Yingru, ZHU Jinlan. Analysis of risk factors of catheter-associated urinary tract infection in ICU and the nursing countermeasures[J]. Journal of Clinical Medicine in Practice, 2014, (22): 75-77. DOI: 10.7619/jcmp.201422023 |
| [9] | ZHANG Jifang. Research on occurrence of macrosomia and its related risk factors[J]. Journal of Clinical Medicine in Practice, 2014, (3): 116-118. DOI: 10.7619/jcmp.201403041 |
| [10] | WEI Shiyou, WANG Yanlin. Study on risk factors for relapse of stroke in young people[J]. Journal of Clinical Medicine in Practice, 2013, (17): 16-19. DOI: 10.7619/jcmp.201317005 |
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: